APA (7th ed.) Citation

DE, S., YIM, E., AMA, A., SIA, T., & EM, E. (2025). Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?". Pediatric nephrology (Berlin, Germany), 40(10), 3329. https://doi.org/10.1007/s00467-025-06925-9

Chicago Style (17th ed.) Citation

DE, Sallam, Elhenawy YIM, Ahmed AMA, Taha SIA, and Elsayed EM. "Response to: "Is Sclerostin a True Mediator of Diabetic Nephropathy, or Just a Surrogate of Altered Bone Metabolism?"." Pediatric Nephrology (Berlin, Germany) 40, no. 10 (2025): 3329. https://doi.org/10.1007/s00467-025-06925-9.

MLA (9th ed.) Citation

DE, Sallam, et al. "Response to: "Is Sclerostin a True Mediator of Diabetic Nephropathy, or Just a Surrogate of Altered Bone Metabolism?"." Pediatric Nephrology (Berlin, Germany), vol. 40, no. 10, 2025, p. 3329, https://doi.org/10.1007/s00467-025-06925-9.